Tech Company Financing Transactions
Allegro Diagnostics Funding Round
On 3/7/2008, Allegro Diagnostics raised $4 million in Series A funding from Kodiak Venture Partners and Catalyst Health Ventures.
Transaction Overview
Company Name
Announced On
3/7/2008
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors
Kodiak Venture Partners (Lead Investor) (Andrey Zarur)
Catalyst Health Ventures (Josh Phillips)
Proceeds Purpose
Dan Rippy, President and CEO of Allegro Diagnostics said, "The Series A financing will enable us to take our first product, based on intellectual property developed at the Boston University School of Medicine, into the clinic to provide earlier, more accurate diagnosis of suspected lung cancer for patients and their doctors."
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6 Clock Tower Pl. 225
Maynard, MA 01754
USA
Maynard, MA 01754
USA
Phone
Website
Email Address
Overview
Allegro Diagnostics is a leader in the field of gene expression molecular diagnostic testing for lung cancer and other diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Webb
Chief Financial Officer
Bill Johnson
VP - R & D
Duncan Whitney
Browse more venture capital transactions:
Prev: 3/6/2008: TransEngen venture capital transaction
Next: 3/7/2008: Ocular Therapeutix venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs